Drug comparisons
Tirzepatide vs Ertugliflozin
Compare Tirzepatide (Mounjaro) vs Ertugliflozin (Steglatro) for T2 diabetes. Dual GIP/GLP-1 vs SGLT2: A1C, weight loss, CV/renal benefits vs GI vs infection risks.
No comparison dimensions are available for this page.
Clinical context
Type 2 diabetes patients comparing weekly dual incretin agonist tirzepatide against oral SGLT2 inhibitor ertugliflozin for control, weight, and organ protection.
Bottom line
Tirzepatide typically outperforms ertugliflozin in A1C and weight loss for T2D but ertugliflozin offers oral convenience and cardiorenal benefits.
All medication comparisons